Skip to Main Content

Paper Details

Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers.
Nephrol Dial Transplant
186
2014
AKI, Acute kidney injury, IGFBP7, Kidney Disease, TIMP-2, Tissue inhibitor of metalloproteinases (TIMP)-2, critically ill, insulin-like growth factor binding protein (IGFBP)7, patients
Author NameAffiliation
Eric HosteGhent University Hospital, Ghent University, and Research Foundation-Flanders (FWO)
Peter A McCulloughBaylor University Medical Center, Baylor Heart and Vascular Institute, Baylor Jack and Jane Hamilton Heart and Vascular Hospital, TX The Heart Hospital
Kianoush B KashaniMayo Clinic
Lakhmir S ChawlaVeterans Affairs Medical Center Department of Anesthesiology and Critical Care Medicine, George Washington University
Michael JoannidisMedical University Innsbruck
Andrew D ShawVanderbilt University Medical Center
Thorsten FeldkampUniversity Hospital Essen, University Duisburg-Essen, University Hospital Schleswig-Holstein, Christian-Albrechts-University
Jing Shi
Michael G Walker
Michael G Walker
John A KellumCenter for Critical Care Nephrology, University of Pittsburgh
  • 1 - 11

Datasets